Leonardo M. Knijnik

Author of 5 Presentation(s)

02. Acute and Stable Ischemic Heart Disease: Clinical 1117-169

1117-169 - DIRECT ORAL ANTICOAGULANTS STRATEGIES IN ACUTE CORONARY SYNDROMES: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Session
1117 - Acute and Stable Ischemic Heart Disease: Clinical 1
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1117-169
Presentation Rating
 Not Rated
03. Acute and Stable Ischemic Heart Disease: Therapy 1162-143
32. Prevention: Clinical 1209-107
14. Heart Failure and Cardiomyopathies: Therapy 1355-94

1355-94 - ROLE OF ANTICOAGULANTS IN STROKE PREVENTION AMONG HEART FAILURE PATIENTS WITHOUT ATRIAL FIBRILLATION: A NETWORK META-ANALYSIS

Session
1355 - Heart Failure and Cardiomyopathies: Therapy 6
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1355-94
Presentation Rating
 Not Rated
14. Heart Failure and Cardiomyopathies: Therapy 1355-121

1355-121 - BETA-BLOCKERS AND ANGIOTENSIN CONVERSION ENZYME INHIBITORS FOR THE PREVENTION OF ANTHRACYCLINE-INDUCED CARDIOMYOPATHY: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Session
1355 - Heart Failure and Cardiomyopathies: Therapy 6
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1355-121
Presentation Rating
 5

Author of 5 Presentation(s)

02. Acute and Stable Ischemic Heart Disease: Clinical 1117-169

1117-169 - DIRECT ORAL ANTICOAGULANTS STRATEGIES IN ACUTE CORONARY SYNDROMES: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Session
1117 - Acute and Stable Ischemic Heart Disease: Clinical 1
Pathway
02. Acute and Stable Ischemic Heart Disease: Clinical
Presentation Number
1117-169
Presentation Rating
 Not Rated
03. Acute and Stable Ischemic Heart Disease: Therapy 1162-143
32. Prevention: Clinical 1209-107
14. Heart Failure and Cardiomyopathies: Therapy 1355-94

1355-94 - ROLE OF ANTICOAGULANTS IN STROKE PREVENTION AMONG HEART FAILURE PATIENTS WITHOUT ATRIAL FIBRILLATION: A NETWORK META-ANALYSIS

Session
1355 - Heart Failure and Cardiomyopathies: Therapy 6
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1355-94
Presentation Rating
 Not Rated
14. Heart Failure and Cardiomyopathies: Therapy 1355-121

1355-121 - BETA-BLOCKERS AND ANGIOTENSIN CONVERSION ENZYME INHIBITORS FOR THE PREVENTION OF ANTHRACYCLINE-INDUCED CARDIOMYOPATHY: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

Session
1355 - Heart Failure and Cardiomyopathies: Therapy 6
Speakers
Pathway
14. Heart Failure and Cardiomyopathies: Therapy
Presentation Number
1355-121
Presentation Rating
 5